Company Oramed Pharmaceuticals, Inc. Xetra
Equities
OJU
US68403P1049
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
03:36pm | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
03:00pm | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/13/14 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09/22/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
Arie Mayer
BRD | Director/Board Member | 67 | 05/19/05 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,628,924 | 35,961,754 ( 88.51 %) | 0 | 88.51 % |
Company contact information
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.com![address Oramed Pharmaceuticals, Inc.(OJU)](https://cdn.zonebourse.com/static/address/493413.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+31.11% | 5.27TCr | |
+37.49% | 3.9TCr | |
-9.23% | 3.85TCr | |
+28.09% | 3.04TCr | |
-12.26% | 2.64TCr | |
+11.28% | 2.61TCr | |
+44.68% | 1.42TCr | |
+32.67% | 1.26TCr | |
-5.40% | 1.15TCr |
- Stock Market
- Equities
- ORMP Stock
- OJU Stock
- Company Oramed Pharmaceuticals, Inc.